Information Links
Mims
Main Navigation
Drugs
Conditions
ArticlesCardiovascular news
Half of patients on statins do not reach cholesterol goals, study shows
Half of patients prescribed statins fail to reach their...
Vitamin D and omega-3 do not prevent cancer or cardiovascular disease, major trial suggests
Neither vitamin D nor omega-3 supplements are effective...
NICE updates chronic heart failure guideline
NICE has updated its guideline on chronic heart failure...
Low-dose aspirin 'ineffective' for cardiovascular prevention in larger patients
Higher aspirin doses may be needed to prevent vascular...
Prescribing antihypertensive drugs as a single pill 'leads to better outcomes'
Patients prescribed a combination of antihypertensive...
New MIMS table summarises monitoring requirements for lipid-lowering drugs
GPs can now use a handy MIMS table to check which tests...
PCSK9 inhibitor licensed for risk reduction in established cardiovascular disease
Repatha (evolocumab) can now be prescribed to reduce...
New MIMS table summarises dosing of novel oral anticoagulants for stroke prevention
GPs can now consult a handy MIMS table to help them...
GPs should no longer prescribe 18 'low value' treatments, NHS England rules
NHS England believes cutting access to the treatments,...
Prescribe quinine with caution in patients at risk of QT prolongation, MHRA advises
New advice highlights that quinine can have effects...
Warfarin interaction warning for miconazole oral gel
Miconazole oral gel should be prescribed with caution...
Stopping statins after stroke linked to higher risk of recurrent stroke
Patients who stop statin therapy 3 to 6 months after...
Anticoagulant linked to rare calciphylaxis risk
Calciphylaxis, a rare but serious condition causing...
Selexipag: new class of treatment for pulmonary artery hypertension reaches prescribers
Uptravi (selexipag), a prostacyclin receptor agonist...
NICE approval for new class of lipid-lowering drugs
NHS clinicians must now have the option to prescribe...
Update: GPs warned about error in cardiovascular risk calculator
GPs have been advised not to use the QRISK2 cardiovascular...
'Innovative' heart failure treatment approved by NICE
A new type of drug to treat heart failure, which could...
Ticagrelor approved for long-term treatment following MI
The antiplatelet treatment Brilique (ticagrelor) can...
New once-daily fibrate/statin combination
Prescribers now have the option to prescribe fenofibrate...
Ezetimibe licensed to reduce the risk of cardiovascular events
Ezetrol (ezetimibe) can now be prescribed to reduce...
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
